Active Ingredient Sorafenib

Active Ingredient Details

What is Sorafenib?

A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy.

How many products in the NDC database contain Sorafenib?

The NDC database has 10 products with the active ingredient Sorafenib. The following table lists all the products that have this active ingredient.

NDC Products with Sorafenib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
12527-8488Proprietary Name: SorafenibTablet, Film CoatedBayer Pharma AgACTIVE
13668-682Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralTorrent Pharmaceuticals LimitedACTIVE
24979-715Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralTwi Pharmaceuticals Usa, Inc.ACTIVE
47049-033Proprietary Name: Sorafenib TabletTablet, Film CoatedPatheon France S.a.sACTIVE
47049-848Proprietary Name: SorafenibTablet, Film CoatedPatheon France S.a.s.ACTIVE
50419-488Proprietary Name: Nexavar SorafenibTablet, Film CoatedOralBayer Healthcare Pharmaceuticals Inc.ACTIVE
50419-489Proprietary Name: Nexavar SorafenibTablet, Film CoatedOralBayer Healthcare Pharmaceuticals Inc.ACTIVE
51407-760Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralGolden State Medical Supply, Inc.ACTIVE
51990-201Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralYabao Pharmaceutical Co., Ltd. BeijingACTIVE
86184-366Proprietary Name: SorafenibPowderMaeda IncACTIVE
<